(Q51493788)

5 April 2018

title

Clinicians can help their patients control postprandial hyperglycemia as a means of reducing cardiovascular risk. (English)

1 reference

5 April 2018

1 reference

1

John E Gerich

1 reference

5 April 2018

publication date

1 July 2006

1 reference

5 April 2018

The Science of Diabetes Self-Management and Care

published in

1 reference

5 April 2018

volume

32

1 reference

5 April 2018

issue

4

1 reference

5 April 2018

page(s)

513-4, 520-2

1 reference

5 April 2018

Glycemic control from 1988 to 2000 among U.S. adults diagnosed with type 2 diabetes: a preliminary report

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0145721706290832

Risk factors for myocardial infarction and death in newly detected NIDDM: the Diabetes Intervention Study, 11-year follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0145721706290832

Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose. The Funagata Diabetes Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0145721706290832

High blood glucose concentration is a risk factor for mortality in middle-aged nondiabetic men. 20-year follow-up in the Whitehall Study, the Paris Prospective Study, and the Helsinki Policemen Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0145721706290832

The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0145721706290832

Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0145721706290832

Regression of carotid atherosclerosis by control of postprandial hyperglycemia in type 2 diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0145721706290832

Therapy focused on lowering postprandial glucose, not fasting glucose, may be superior for lowering HbA1c. IOEZ Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0145721706290832

Contributions of fasting and postprandial plasma glucose increments to the overall diurnal hyperglycemia of type 2 diabetic patients: variations with increasing levels of HbA(1c).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0145721706290832

Diagnostic and therapeutic implications of relationships between fasting, 2-hour postchallenge plasma glucose and hemoglobin a1c values

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0145721706290832

Glycemic characteristics in continuously monitored patients with type 1 and type 2 diabetes: normative values

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0145721706290832

Postchallenge hyperglycemia in a national sample of U.S. adults with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0145721706290832

Self-monitoring of blood glucose as part of a multi-component therapy among non-insulin requiring type 2 diabetes patients: a meta-analysis (1966-2004).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0145721706290832

21 January 2018

Identifiers

DOI

10.1177/0145721706290832

1 reference

5 April 2018

1 reference

5 April 2018